| scholarly article | Q13442814 |
| P2093 | author name string | Juan Wu | |
| Laura L Mulloy | |||
| Rajan Kapoor | |||
| Vera Portik-Dobos | |||
| Anatolij Horuzsko | |||
| Daniel D Horuzsko | |||
| Muralidharan Jagadeesan | |||
| Maureen Ezeakile | |||
| P2860 | cites work | Mobilizing dendritic cells for tolerance by engagement of immune inhibitory receptors for HLA-G. | Q44645237 |
| Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer. | Q46925575 | ||
| The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G. | Q53625470 | ||
| ORIGINAL ARTICLE: Soluble Human Leukocyte Antigen-G Isoforms in Maternal Plasma in Early and Late Pregnancy | Q59910349 | ||
| HLA-G gene polymorphism in human placentas: possible association of G*0106 allele with preeclampsia and miscarriage | Q61841593 | ||
| Prognostic relevance of soluble human leukocyte antigen–G and total human leukocyte antigen class I molecules in lung cancer patients | Q62513500 | ||
| The clinical significance of soluble human leukocyte antitgen class-I, ICTP, and RANKL molecules in multiple myeloma patients | Q62513505 | ||
| Neoplastic B-cell growth is impaired by HLA-G/ILT2 interaction | Q83730577 | ||
| Soluble HLA-G in heart transplantation: their relationship to rejection episodes and immunosuppressive therapy | Q83832004 | ||
| Human leukocyte antigen-G in the male reproductive system and in seminal plasma | Q84669741 | ||
| Multimeric structures of HLA-G isoforms function through differential binding to LILRB receptors | Q24293562 | ||
| Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6--STAT3 signaling pathway | Q24321398 | ||
| Disulfide bond-mediated dimerization of HLA-G on the cell surface. | Q24541505 | ||
| Immunogenicity of Human Mesenchymal Stem Cells in HLA-Class I-Restricted T-Cell Responses Against Viral or Tumor-Associated Antigens | Q27489354 | ||
| HLA-G molecules: from maternal-fetal tolerance to tissue acceptance | Q28237673 | ||
| Beyond the increasing complexity of the immunomodulatory HLA-G molecule | Q28272361 | ||
| HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells | Q28304268 | ||
| Synthetic HLA-G proteins for therapeutic use in transplantation. | Q30543621 | ||
| HLA-G: a shield against inflammatory aggression | Q33954904 | ||
| Tolerization of dendritic cells by HLA-G. | Q33985802 | ||
| Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/ regulatory T cells | Q33993682 | ||
| Soluble HLA-G expression and renal graft acceptance. | Q33996904 | ||
| HLA-G expression in human embryonic stem cells and preimplantation embryos | Q34025391 | ||
| Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17. | Q34026483 | ||
| Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis | Q34065286 | ||
| Bone marrow-infiltrating human neuroblastoma cells express high levels of calprotectin and HLA-G proteins | Q34130792 | ||
| Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d) | Q35133849 | ||
| HLA-G and immune tolerance in pregnancy | Q36109416 | ||
| KIR2DL4 (CD158d): An activation receptor for HLA-G. | Q36174860 | ||
| Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention? | Q36184793 | ||
| Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor | Q36364483 | ||
| Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts | Q36380361 | ||
| Human leukocyte antigen-G is frequently expressed in glioblastoma and may be induced in vitro by combined 5-aza-2'-deoxycytidine and interferon-γ treatments: results from a multicentric study | Q36582874 | ||
| The maternal HLA-G 1597ΔC null mutation is associated with increased risk of pre-eclampsia and reduced HLA-G expression during pregnancy in African-American women | Q36629793 | ||
| HLA-G homodimer-induced cytokine secretion through HLA-G receptors on human decidual macrophages and natural killer cells. | Q37153660 | ||
| Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts | Q37157534 | ||
| A critical look at HLA-G. | Q37185857 | ||
| HLA-G and inflammatory diseases | Q37239962 | ||
| The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells | Q37809765 | ||
| Human leucocyte antigen class Ib molecules in pregnancy success and early pregnancy loss | Q37960447 | ||
| Immunosuppressive microenvironment in neuroblastoma | Q38117379 | ||
| Molecular pathways: human leukocyte antigen G (HLA-G). | Q38125170 | ||
| Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding. | Q39143880 | ||
| HLA-G1 and HLA-G5 active dimers are present in malignant cells and effusions: the influence of the tumor microenvironment. | Q39334954 | ||
| Increase in HLA-G1 proteolytic shedding by tumor cells: a regulatory pathway controlled by NF-kappaB inducers. | Q40214384 | ||
| Placental cell expression of HLA-G2 isoforms is limited to the invasive trophoblast phenotype | Q40614057 | ||
| Special organization of the HLA-G protein on the cell surface | Q40619245 | ||
| HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor | Q40705349 | ||
| Complexes of HLA-G protein on the cell surface are important for leukocyte Ig-like receptor-1 function | Q44521264 | ||
| The long-term immunosuppressive effects of disulfide-linked HLA-G dimer in mice with collagen-induced arthritis | Q44555498 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P304 | page(s) | 153981 | |
| P577 | publication date | 2014-03-30 | |
| P1433 | published in | Journal of Immunology Research | Q26841936 |
| P1476 | title | HLA-G dimers in the prolongation of kidney allograft survival | |
| P478 | volume | 2014 |
| Q38839474 | Soluble monomers, dimers and HLA-G-expressing extracellular vesicles: the three dimensions of structural complexity to use HLA-G as a clinical biomarker | cites work | P2860 |
Search more.